-
ILUS Signs Letter of Intent to Acquire a British Manufacturer of Autonomous Vehicles While Completing its Next Phase of Restructuring for Anticipated Growth
[ad_1] NEW YORK, NY – (NewMediaWire) – February 20, 2024 – ILUS International Inc. (OTC: ILUS) is a Mergers and…
Read More » -
Sigyn Therapeutics Announces Filing of 2023 Annual Report on SEC Form 10-K
[ad_1] SAN DIEGO, CA – (NewMediaWire) – February 21, 2024 – Sigyn Therapeutics, Inc. (“Sigyn Therapeutics” or the “Company”) (OTCQB: “SIGYD” –…
Read More » -
News
HKTDC’s Major Focus Areas Promote Hong Kong’s Advantages
[ad_1] Boosting Diverse Economic Development and Reinforcing the City’s Role as a Global Business and C&E Hub HONG KONG, –…
Read More » -
Latest research redefines neurodevelopmental risks, outcomes for congenital heart disease
[ad_1] Statement Highlights: A new American Heart Association scientific statement updates more than a decade of research identifying, managing…
Read More »